CR8800A - Regimenes y equipos anticonceptivos de antagonistas del receptor de progesterona - Google Patents
Regimenes y equipos anticonceptivos de antagonistas del receptor de progesteronaInfo
- Publication number
- CR8800A CR8800A CR8800A CR8800A CR8800A CR 8800 A CR8800 A CR 8800A CR 8800 A CR8800 A CR 8800A CR 8800 A CR8800 A CR 8800A CR 8800 A CR8800 A CR 8800A
- Authority
- CR
- Costa Rica
- Prior art keywords
- conceptive
- concepts
- systems
- progesterone
- receiver
- Prior art date
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title abstract 3
- 230000001380 anti-conceptive effect Effects 0.000 title 1
- 239000003433 contraceptive agent Substances 0.000 title 1
- 229960003387 progesterone Drugs 0.000 title 1
- 239000000186 progesterone Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporciona un metodo para la anticoncepcion, que comprende suministrar de 21 a 27 dias consecutivos de uno o mas antagonistas de PR en la ausencia de una progestina, estrogeno, u otro compuesto esteroidal, seguido por de 1 a 7 dias sin ningun agente activo; tambien se describe un equipo farmaceuticamente util para facilitar el suministro de este regimen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58588304P | 2004-07-07 | 2004-07-07 | |
| US67613505P | 2005-04-29 | 2005-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8800A true CR8800A (es) | 2007-08-28 |
Family
ID=35106665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8800A CR8800A (es) | 2004-07-07 | 2006-12-07 | Regimenes y equipos anticonceptivos de antagonistas del receptor de progesterona |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060009509A1 (es) |
| EP (1) | EP1773323A1 (es) |
| JP (1) | JP2008505906A (es) |
| KR (1) | KR20070039912A (es) |
| AR (1) | AR049664A1 (es) |
| AU (1) | AU2005271974A1 (es) |
| BR (1) | BRPI0512993A (es) |
| CA (1) | CA2571198A1 (es) |
| CR (1) | CR8800A (es) |
| EC (1) | ECSP077131A (es) |
| GT (1) | GT200500186A (es) |
| IL (1) | IL180238A0 (es) |
| MX (1) | MXPA06014580A (es) |
| NO (1) | NO20070377L (es) |
| PA (1) | PA8638501A1 (es) |
| PE (1) | PE20060485A1 (es) |
| RU (1) | RU2006144069A (es) |
| SV (1) | SV2006002166A (es) |
| TW (1) | TW200605880A (es) |
| WO (1) | WO2006017075A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| GB0121285D0 (en) * | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| AR049707A1 (es) | 2004-07-07 | 2006-08-30 | Wyeth Corp | Regimenes y kits de progestina ciclica |
| JP5017109B2 (ja) | 2004-07-09 | 2012-09-05 | ザ・ポピュレイション・カウンシル,インコーポレイテッド | プロゲステロン受容体モジュレーターを含有する徐放性組成物 |
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| MY144968A (en) | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| EP2073806B1 (en) | 2006-10-12 | 2012-02-15 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| HRP20150882T1 (hr) | 2008-10-17 | 2015-09-25 | Xenon Pharmaceuticals Inc. | Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva |
| WO2010119029A1 (en) | 2009-04-14 | 2010-10-21 | Laboratoire Hra-Pharma | Method for on-demand contraception |
| JP5643818B2 (ja) | 2009-06-18 | 2014-12-17 | ファイザー・インク | Katii阻害剤としての二環式および三環式化合物 |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| PE20170202A1 (es) | 2009-10-14 | 2017-03-24 | Xenon Pharmaceuticals Inc | Metodos sinteticos para compuestos espiro-oxoindol |
| RU2596488C2 (ru) | 2010-02-26 | 2016-09-10 | Ксенон Фармасьютикалз Инк. | Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов |
| US9375437B2 (en) * | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
| DK2646443T3 (en) | 2010-12-01 | 2014-11-17 | Pfizer | CAT-II inhibitors |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| BR112015023273A2 (pt) * | 2013-03-14 | 2017-07-18 | Hra Pharma Lab | método para programar a ovulação. |
| AR103636A1 (es) | 2015-02-05 | 2017-05-24 | Teva Pharmaceuticals Int Gmbh | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol |
| JP2018522854A (ja) | 2015-06-22 | 2018-08-16 | リポカイン インコーポレーテッド | 17−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6444668B1 (en) * | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
-
2005
- 2005-07-04 GT GT200500186A patent/GT200500186A/es unknown
- 2005-07-06 PE PE2005000782A patent/PE20060485A1/es not_active Application Discontinuation
- 2005-07-06 MX MXPA06014580A patent/MXPA06014580A/es unknown
- 2005-07-06 RU RU2006144069/15A patent/RU2006144069A/ru not_active Application Discontinuation
- 2005-07-06 AR ARP050102807A patent/AR049664A1/es unknown
- 2005-07-06 SV SV2005002166A patent/SV2006002166A/es not_active Application Discontinuation
- 2005-07-06 JP JP2007520434A patent/JP2008505906A/ja active Pending
- 2005-07-06 CA CA002571198A patent/CA2571198A1/en not_active Abandoned
- 2005-07-06 EP EP05771038A patent/EP1773323A1/en not_active Withdrawn
- 2005-07-06 PA PA20058638501A patent/PA8638501A1/es unknown
- 2005-07-06 WO PCT/US2005/023798 patent/WO2006017075A1/en not_active Ceased
- 2005-07-06 US US11/175,549 patent/US20060009509A1/en not_active Abandoned
- 2005-07-06 TW TW094122826A patent/TW200605880A/zh unknown
- 2005-07-06 BR BRPI0512993-1A patent/BRPI0512993A/pt not_active Application Discontinuation
- 2005-07-06 KR KR1020077000184A patent/KR20070039912A/ko not_active Withdrawn
- 2005-07-06 AU AU2005271974A patent/AU2005271974A1/en not_active Abandoned
-
2006
- 2006-12-07 CR CR8800A patent/CR8800A/es not_active Application Discontinuation
- 2006-12-21 IL IL180238A patent/IL180238A0/en unknown
-
2007
- 2007-01-05 EC EC2007007131A patent/ECSP077131A/es unknown
- 2007-01-19 NO NO20070377A patent/NO20070377L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20060009509A1 (en) | 2006-01-12 |
| NO20070377L (no) | 2007-02-07 |
| ECSP077131A (es) | 2007-02-28 |
| TW200605880A (en) | 2006-02-16 |
| WO2006017075A1 (en) | 2006-02-16 |
| RU2006144069A (ru) | 2008-08-20 |
| PE20060485A1 (es) | 2006-06-24 |
| CA2571198A1 (en) | 2006-02-16 |
| AU2005271974A1 (en) | 2006-02-16 |
| PA8638501A1 (es) | 2006-07-03 |
| MXPA06014580A (es) | 2007-03-23 |
| BRPI0512993A (pt) | 2008-04-22 |
| EP1773323A1 (en) | 2007-04-18 |
| SV2006002166A (es) | 2006-05-09 |
| IL180238A0 (en) | 2007-07-04 |
| GT200500186A (es) | 2006-03-02 |
| KR20070039912A (ko) | 2007-04-13 |
| JP2008505906A (ja) | 2008-02-28 |
| AR049664A1 (es) | 2006-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077131A (es) | Regímenes y los juegos de anticonceptivos del antagonista del receptor de progesterona | |
| AR049707A1 (es) | Regimenes y kits de progestina ciclica | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| ATE369125T1 (de) | Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe | |
| NZ615430A (en) | Method for on-demand contraception | |
| DK1768625T3 (da) | Sammensætninger med vedvarende frigørelse indeholdende progesteron-receptormodulatorer | |
| CR7610A (es) | Uso de derivados de thio-oxindol en el tratamiento de condiciones realcionadas con la hormona | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| TW200605882A (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
| NO20062945L (no) | Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner | |
| NO20090578L (no) | Farmasoytisk sammensetning inneholdende en tetrahydrofolsyre | |
| NZ600907A (en) | Progestin/estradiol transdermal gel | |
| CR8709A (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| JP2010539153A5 (es) | ||
| AR043013A1 (es) | Composicion farmaceutica destinada al tratamiento de la endometriosis | |
| PE20090805A1 (es) | COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL | |
| UY28334A1 (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrógenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas. | |
| DK1635843T3 (da) | Terapi, der omfatter dienogest for hormonerstatning og depression | |
| ECSP109872A (es) | Estratrienos 8-beta-sustituidos como estrógenos de acción selectiva | |
| DOP2007000122A (es) | Forma farmacologica peroral para anticoncepcion | |
| DOP2006000037A (es) | Forma farmacológica peroral sólida para la anticoncepción | |
| AR036227A1 (es) | USO DE LIGANDOS SELECTIVOS PARA ERa PARA REGULAR LA FERTILIDAD. | |
| UY29263A1 (es) | Emplasto transdérmico con ligandos específicos de progesterona a (prasl) como principio activo | |
| PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
| DOP2005000263A (es) | Emplasto transdermico con ligandos especificos de progesterona a (prasl) como principio activo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |